MedPath

INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE

INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE logo
🇯🇵Japan
Ownership
-
Established
1995-01-01
Employees
-
Market Cap
-
Website
https://www.iuhw.ac.jp/

Clinical Trials

117

Active:1
Completed:54

Trial Phases

4 Phases

Phase 2:1
Phase 3:1
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (114 trials with phase data)• Click on a phase to view related trials

Not Applicable
110 (96.5%)
Phase 4
2 (1.8%)
Phase 2
1 (0.9%)
Phase 3
1 (0.9%)

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Phase 4
Recruiting
Conditions
Opioid-Induced Constipation (OIC)
Interventions
Drug: Placebo
First Posted Date
2025-06-26
Last Posted Date
2025-07-02
Lead Sponsor
International University of Health and Welfare
Target Recruit Count
120
Registration Number
NCT07038551
Locations
🇯🇵

International university of health and welfare Narita hospital, Narita, Japan

Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction

Not Applicable
Not yet recruiting
Conditions
Chronic Intestinal Pseudo-obstruction
First Posted Date
2025-04-24
Last Posted Date
2025-04-24
Lead Sponsor
International University of Health and Welfare
Target Recruit Count
20
Registration Number
NCT06943417
Locations
🇯🇵

International university health and welfare Narita hospital, Narita, Japan

Elobixibat for Chronic Constipation Without Defecation Desire

Phase 4
Terminated
Conditions
Chronic Constipation
Interventions
First Posted Date
2023-01-30
Last Posted Date
2023-03-09
Lead Sponsor
International University of Health and Welfare
Target Recruit Count
40
Registration Number
NCT05703464
Locations
🇯🇵

International university health and welfare Narita hospital, Narita, Japan

Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)

Phase 2
Active, not recruiting
Conditions
Pulmonary Arterial Hypertension
Interventions
First Posted Date
2023-01-11
Last Posted Date
2024-07-08
Lead Sponsor
International University of Health and Welfare
Target Recruit Count
20
Registration Number
NCT05679570
Locations
🇯🇵

Chiba University Hospital, Chiba, Japan

🇯🇵

Kyushu University Hospital, Fukuoka, Japan

🇯🇵

Kagoshima University Hospital, Kagoshima, Japan

and more 6 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath